{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:30:35Z","timestamp":1786321835070,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,9]]},"DOI":"10.7759\/cureus.114228","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:23:43Z","timestamp":1786321423000},"source":"Crossref","is-referenced-by-count":0,"title":["Costs of Surveillance Care After Definitive Treatment of Head and Neck Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Analysis"],"prefix":"10.7759","author":[{"given":"Allison","family":"Verbyla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharvil C","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary V","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330805","article-title":"Global burden of head and neck cancer from 1990 to 2021: a comprehensive analysis and projections to 2030 based on the global burden of disease study 2021","volume":"20","author":"Deng M","year":"2025","unstructured":"Deng M, Lin Y, Yan L, Fei Z, Chen C, Ding J. Global burden of head and neck cancer from 1990 to 2021: a comprehensive analysis and projections to 2030 based on the global burden of disease study 2021. PLoS One. 2025, 20:e0330805. 10.1371\/journal.pone.0330805","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.21733","article-title":"Head and neck cancer: a review","volume":"335","author":"Dunn LA","year":"2026","unstructured":"Dunn LA, Ho AL, Pfister DG. Head and neck cancer: a review. JAMA. 2026, 335:531-41. 10.1001\/jama.2025.21733","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein DJ","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, et al.. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003, 21:92-8. 10.1200\/JCO.2003.01.008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang KK","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, et al.. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010, 363:24-35. 10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.12.024","article-title":"Imaging and biomarker surveillance for head and neck squamous cell carcinoma: a systematic review and American Radium Society appropriate use criteria statement","volume":"119","author":"Hanna GJ","year":"2024","unstructured":"Hanna GJ, Chang SS, Siddiqui F, et al.. Imaging and biomarker surveillance for head and neck squamous cell carcinoma: a systematic review and American Radium Society appropriate use criteria statement. Int J Radiat Oncol Biol Phys. 2024, 119:786-802. 10.1016\/j.ijrobp.2023.12.024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Head and Neck Cancers. (2025). Accessed. June 26, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2023.08.008","article-title":"ACR Appropriateness Criteria\u00ae staging and post-therapy assessment of head and neck cancer","volume":"20","author":"Gule-Monroe MK","year":"2023","unstructured":"Gule-Monroe MK, Calle S, Policeni B, et al.. ACR Appropriateness Criteria\u00ae staging and post-therapy assessment of head and neck cancer. J Am Coll Radiol. 2023, 20:S521-64. 10.1016\/j.jacr.2023.08.008","journal-title":"J Am Coll Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21343","article-title":"American Cancer Society head and neck cancer survivorship care guideline","volume":"66","author":"Cohen EE","year":"2016","unstructured":"Cohen EE, LaMonte SJ, Erb NL, et al.. American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016, 66:203-39. 10.3322\/caac.21343","journal-title":"CA Cancer J Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2019.1934","article-title":"Association of NCCN-recommended posttreatment surveillance with outcomes in patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"145","author":"Masroor F","year":"2019","unstructured":"Masroor F, Corpman D, Carpenter DM, Ritterman Weintraub M, Cheung KH, Wang KH. Association of NCCN-recommended posttreatment surveillance with outcomes in patients with HPV-associated oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2019, 145:903-8. 10.1001\/jamaoto.2019.1934","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.02.005","article-title":"Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy","volume":"157","author":"Wong ET","year":"2021","unstructured":"Wong ET, Huang SH, O'Sullivan B, et al.. Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy. Radiother Oncol. 2021, 157:255-62. 10.1016\/j.radonc.2021.02.005","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31983","article-title":"Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy","volume":"125","author":"Ng SP","year":"2019","unstructured":"Ng SP, Pollard C 3rd, Berends J, et al.. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019, 125:1823-9. 10.1002\/cncr.31983","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2022.2561","article-title":"Evaluation of optimal assessment schedules for surveillance after definitive locoregional treatment of locally advanced head and neck cancer: a retrospective cohort study with parametric modeling of event-free survival","volume":"148","author":"Lee HI","year":"2022","unstructured":"Lee HI, Lee J, Lee JH, Wu HG, Kim JH, Kim Y, Eom KY. Evaluation of optimal assessment schedules for surveillance after definitive locoregional treatment of locally advanced head and neck cancer: a retrospective cohort study with parametric modeling of event-free survival. JAMA Otolaryngol Head Neck Surg. 2022, 148:1059-67. 10.1001\/jamaoto.2022.2561","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera BS","year":"2020","unstructured":"Chera BS, Kumar S, Shen C, et al.. Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer. J Clin Oncol. 2020, 38:1050-8. 10.1200\/JCO.19.02444","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.02.012","article-title":"Detectable postoperative circulating tumor human papillomavirus DNA and association with recurrence in patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"113","author":"Routman DM","year":"2022","unstructured":"Routman DM, Kumar S, Chera BS, et al.. Detectable postoperative circulating tumor human papillomavirus DNA and association with recurrence in patients with HPV-associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2022, 113:530-8. 10.1016\/j.ijrobp.2022.02.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer","volume":"25","author":"Chera BS","year":"2019","unstructured":"Chera BS, Kumar S, Beaty BT, et al.. Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer. Clin Cancer Res. 2019, 25:4682-90. 10.1158\/1078-0432.CCR-19-0211","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.106874","article-title":"Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance","volume":"155","author":"Roof SA","year":"2024","unstructured":"Roof SA, Jabalee J, Rettig EM, et al.. Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance. Oral Oncol. 2024, 155:106874. 10.1016\/j.oraloncology.2024.106874","journal-title":"Oral Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.105721","article-title":"The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: a simulation","volume":"126","author":"Ward MC","year":"2022","unstructured":"Ward MC, Miller JA, Walker GV, Moeller BJ, Koyfman SA, Shah C. The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: a simulation. Oral Oncol. 2022, 126:105721. 10.1016\/j.oraloncology.2022.105721","journal-title":"Oral Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44783","article-title":"Estimated cost of circulating tumor DNA for posttreatment surveillance of human papillomavirus-associated oropharyngeal cancer","volume":"5","author":"Kowalchuk RO","year":"2022","unstructured":"Kowalchuk RO, Kamdem Talom BC, Van Abel KM, Ma DM, Waddle MR, Routman DM. Estimated cost of circulating tumor DNA for posttreatment surveillance of human papillomavirus-associated oropharyngeal cancer. JAMA Netw Open. 2022, 5:e2144783. 10.1001\/jamanetworkopen.2021.44783","journal-title":"JAMA Netw Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgz029","article-title":"Updated overview of the SEER-Medicare data: enhanced content and applications","volume":"2020","author":"Enewold L","year":"2020","unstructured":"Enewold L, Parsons H, Zhao L, et al.. Updated overview of the SEER-Medicare data: enhanced content and applications. J Natl Cancer Inst Monogr. 2020, 2020:3-13. 10.1093\/jncimonographs\/lgz029","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007, 4:e296. 10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"ref21","unstructured":"Healthcare Common Procedure Coding System (HCPCS). (2026). Accessed. April 17, 2026: https:\/\/www.cms.gov\/medicare\/coding-billing\/healthcare-common-procedure-system."},{"key":"ref22","unstructured":"CPI inflation calculator. Bureau of Labor Statistics. (2026). Accessed: April 17, 2026: https:\/\/www.bls.gov\/data\/inflation_calculator.htm."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto AB","year":"2020","unstructured":"Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020, 29:1304-12. 10.1158\/1055-9965.EPI-19-1534","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref24","unstructured":"License for Use of Current Procedural Terminology, Fourth Edition (\u201cCPT\u00ae\u201d). (2026). Accessed. April 17, 2026: https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/511301-costs-of-surveillance-care-after-definitive-treatment-of-head-and-neck-cancer-a-surveillance-epidemiology-and-end-results-seer-medicare-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:23:44Z","timestamp":1786321424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/511301-costs-of-surveillance-care-after-definitive-treatment-of-head-and-neck-cancer-a-surveillance-epidemiology-and-end-results-seer-medicare-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.114228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}